Seligman Common Stock R
100 Park Avenue 7th Floor New York NY 10017
Map
Phone: 800-221-2450
| Category: | Large Blend | | Fund Family: | Seligman | | Net Assets: | 1.50M | | Year-to-Date Return: | -40.25% | | Yield: | 2.88% | | Morningstar Rating: |  | | Fund Inception Date: | 30-Apr-03 |
|
John B. Cunningham
Lead Manager since
13-Sep-04 | | | Cunningham is a managing director and chief investment officer of Seligman. He is also vice president and portfolio manager of Seligman Common Stock Fund, Inc. and Tri-Continental Corporation. Prior to joining Seligman, he was, beginning in 2001, a managing director, senior portfolio of Salomon Brothers Asset Management (SBAM) and Group Head of SBAMs Equity Team. Prior to 2001, he was a director, portfolio manager of SBAM. |
| Min Initial Investment: | $0 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks total return. The fund invests at least 80% of net assets in common stocks that are broadly diversified among a number of industries. It usually invests in the common stock of larger US companies with market capitalizations over $3 billion. It may invest in companies of any size. The fund also invests in fixed-income securities and cash equivalents. It may invest up to 15% of assets in illiquid securities and 10% of assets directly in foreign securities. The fund may invest up to 10% of assets in exchange-traded funds and 10% of assets in equity-linked securities. |
| Last Dividend
(19-Sep-08):
| 0.03 | | Last Cap Gain
(17-Jul-08):
| 0.29 | | Annual Holdings Turnover
| 119.00% | | Average for Category:
| 71.85% |
|
| Expense | SCSRX | Category
Avg | | Total Expense Ratio: | 1.58%
| 1.11% | | Max 12b1 Fee: | 0.50%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.14% | | Max Deferred Sales Load: | 1.00%
| 2.63% | | 3 Yr Expense Projection*: |
$499 | $572 | | 5 Yr Expense Projection*: |
$860 | $876 | | 10 Yr Expense Projection*: |
$1,878 | $2,504 |
|
|
2.63% Nasdaq 0.00%
Profile
